Sign In
Buy MYO
$1.10
+0.0400 (+3.77%)
At Close: Jun 03, 2026
Myomo To Present at the MicroCap Rodeo Presents The Windy City Roundup 2022
04:30pm, Wednesday, 05'th Oct 2022
BOSTON, MA / ACCESSWIRE / October 5, 2022 / Myomo, Inc. (NYSE American:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from
Myomo to Present at the H.C. Wainwright 24th Annual Global Investment Conference
08:30am, Wednesday, 07'th Sep 2022
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
Myomo, Inc.'s (MYO) CEO Paul Gudonis on Q2 2022 Results - Earnings Call Transcript
02:38pm, Saturday, 06'th Aug 2022
Myomo, Inc. (NYSE:MYO ) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Kim Golodetz - Investor Relations, LHA Paul Gudonis - Chief Executive Officer Dave Henry - Chief
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates
08:18pm, Wednesday, 03'rd Aug 2022
Myomo, Inc. (MYO) delivered earnings and revenue surprises of 6.67% and 4.79%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Myomo To Present at the Sidoti Summer Small Cap Virtual Investor Conference
04:05pm, Thursday, 09'th Jun 2022
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
Myomo, Inc. (MYO) CEO Paul Gudonis on Q1 2022 Results - Earnings Call Transcript
07:38pm, Wednesday, 11'th May 2022
Myomo, Inc. (NYSE:MYO ) Q1 2022 Results Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Kim Golodetz - IR, LHA Investor Relations Paul Gudonis - Chief Executive Officer Dave Henr
Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates
07:34pm, Wednesday, 11'th May 2022
Myomo, Inc. (MYO) delivered earnings and revenue surprises of 24.07% and 35.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Kala, Natera top healthcare gainers; Sunshine Biopharma, Myomo lead losers'' pack
03:07pm, Thursday, 10'th Mar 2022 Seeking Alpha
Kala Pharmaceuticals KALA +20%. Natera NTRA +17%. Sunshine Biopharma SBFM -32%. Myomo (MYO) -28%.
Myomo, Inc. (MYO) CEO Paul Gudonis on Q4 2021 Results - Earnings Call Transcript
01:12am, Thursday, 10'th Mar 2022 Seeking Alpha
Myomo GAAP EPS of -$0.52 misses by $0.03, revenue of $4.0M beats by $1.01M
09:16pm, Wednesday, 09'th Mar 2022 Seeking Alpha
Myomo press release (MYO): Q4 GAAP EPS of -$0.52 misses by $0.03.Revenue of $4.0M (+5.5% Y/Y) beats by $1.01M.
Myomo Reports Fourth Quarter and Full Year 2021 Financial Results
09:05pm, Wednesday, 09'th Mar 2022 Business Wire
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months and year ended December 31, 2021. Financial and operational highlights for the fourth quarter of 2021 include the following (all comparisons are with the fourth quarter of 2020, unless otherwise noted): Revenue w
Myomo, Inc. (MYO) CEO Paul Gudonis on Q4 2021 Results - Earnings Call Transcript
08:12pm, Wednesday, 09'th Mar 2022
Myomo, Inc. (MYO) CEO Paul Gudonis on Q4 2021 Results - Earnings Call Transcript
Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates
06:48pm, Wednesday, 09'th Mar 2022
Myomo, Inc. (MYO) delivered earnings and revenue surprises of -6.12% and 34.36%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Myomo To Participate in Two March Investor Conferences
04:15pm, Wednesday, 09'th Mar 2022
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
Myomo Q4 2021 Earnings Preview
10:35pm, Tuesday, 08'th Mar 2022 Seeking Alpha
Myomo (NYSE:MYO) is scheduled to announce Q4 earnings results on Wednesday, March 9th, after market close.The consensus EPS Estimate is -$0.49 (compared to -$0.37 a year ago) and…
